U.S. IT Stock News

If you are wondering whether Rexford Industrial Realty is attractively priced today, the key question is how its current share price lines up with its underlying fundamentals. The stock last closed at US$37.88, with returns of 2.0% over the past week, a 3.9% decline over the past month, and a 2.9% decline both year to date and over the past year, while the three and five year returns sit at 30.3% and 5.8% declines respectively. Recent attention on Rexford Industrial Realty has centered on...

If you are wondering whether KeyCorp's current share price reflects its underlying value, you are not alone. This article is built to help you make sense of that question in a clear, practical way. Over recent periods, the stock has shown mixed returns: about 0.3% over the last week, 1.9% over the past month, 4.2% year to date, 34.9% over 1 year, 42.4% over 3 years and 36.1% over 5 years. These figures may lead some investors to reassess both its potential and its risks. Recent news around...

Viasat recently returned to profitability in its fiscal Q3 2026 with US$25.0 million in net income, supported by a US$420.0 million payment from Ligado, while advancing its Inmarsat acquisition and expanding satellite capacity with the ViaSat-3 F2 program. Alongside new antenna deployments with Astralintu and connected-vehicle voice calling trials, these developments highlight Viasat’s push to deepen its role in global satellite infrastructure and services. We’ll now explore how Viasat’s...

Why Energy Transfer is on investors’ radar today Energy Transfer (ET) is back in focus after recent trading action, with the units last closing at $18.69. You might be weighing how its income profile and long record of pipeline assets fit your portfolio. See our latest analysis for Energy Transfer. The unit price has shown steady upward momentum recently, with a 30 day share price return of 4.12% and a 90 day share price return of 11.85%. The 5 year total shareholder return of 244.46% points...

ServiceNow (NYSE:NOW) has launched Autonomous Workforce and EmployeeWorks, two AI powered platforms aimed at automating complex enterprise workflows. The company is integrating Moveworks technology to bring advanced conversational AI into its ecosystem. Moveworks has received FedRAMP Moderate Authorization, allowing its cloud services to be used in certain U.S. federal government environments. For investors watching NYSE:NOW, these launches come at a time when the stock is trading at...

If you are wondering whether Genius Sports at around US$6.39 is a bargain or just fairly priced, you are not alone. The stock has had a mixed run, with a 0.3% decline over the last week, a 32.8% decline over the last month, a 40.7% decline year to date, a 24.1% decline over the last year, but a 37.7% return over three years. Recent news around Genius Sports has focused on its role as a data and technology provider to sports leagues and betting operators, along with ongoing attention on how...

Earlier in February 2026, Jehoshaphat Research disclosed a short position in GPGI, alleging that the company overstated Husky Technologies’ financial performance and highlighting the unexpected resignations of Husky’s CEO and CFO without immediate successors. This combination of accounting concerns and abrupt leadership changes at the company’s largest earnings contributor has raised fresh questions about GPGI’s post-merger integration and reporting quality. We’ll now examine how these...

If you are wondering whether Citigroup still offers value at its current share price, or if most of the potential upside has already been reflected, this article breaks down what the numbers are really saying about the stock. Citigroup's share price recently closed at US$116.19, with returns of 0.6% over 7 days, 1.2% over 30 days, a 2.1% decline year to date and 51.1% over the past year, plus 150.9% over 3 years and 98.3% over 5 years for longer term context. Recent headlines around...

Beam Therapeutics (BEAM) caught investors attention after a Q4 earnings surprise, a new US$500 million credit facility to back commercialization and pipeline work, and the launch of its PKU program BEAM-304. See our latest analysis for Beam Therapeutics. The Q4 earnings surprise, new PKU program, and US$500 million credit facility have arrived against a backdrop where the latest share price of US$28.92 sits on a 90 day share price return of 14.17%, a year to date share price gain of 6.56%,...

Q4 earnings highlight a strong finish to 2025 Frontline (FRO) just released its fourth quarter and full year 2025 results, with Q4 revenue of US$624.51 million and net income of US$227.93 million standing out against softer full year figures. The company reported Q4 basic and diluted earnings per share from continuing operations of US$1.02, compared with US$0.30 a year earlier. Full year EPS from continuing operations came in at US$1.70 versus US$2.23 in 2024. See our latest analysis for...

Quanta Services (NYSE:PWR) reported quarterly results that exceeded expectations and highlighted strong operational performance. The company completed eight acquisitions in 2025 that expand its footprint across key infrastructure markets. Management outlined double digit growth projections for 2026 and pointed to a record backlog and project pipeline. Quanta is positioning itself around large scale infrastructure shifts, including renewable energy projects and broadband and 5G...

Avantor stock moves after recent performance shift Avantor (AVTR) has come into focus after a recent stretch of weaker share performance, with the stock showing negative returns over the past week, month and past 3 months, as well as over the past year. See our latest analysis for Avantor. At a share price of US$9.01, Avantor’s recent momentum has been weak, with a 30 day share price return of 22.66% and a 1 year total shareholder return of 45.36% pointing to sustained pressure on the...

Intuit and Anthropic have entered a multi year partnership to build custom, secure AI agents for mid market businesses and consumers. The agreement will embed Intuit’s tax, finance, and accounting capabilities directly into Anthropic’s Claude Agent SDK and AI environments. The collaboration aims to support operational automation, financial insights for businesses, and personal finance assistance for individuals. Intuit, listed as NasdaqGS:INTU, is moving deeper into AI by putting its...

In February 2026, Prudential Financial announced and then completed fixed-income offerings, including 4.100% senior unsecured notes due 2031 and 4.650% callable senior unsecured notes due 2036, both issued at 100% price with discounts to the offering price and fixed coupons. These bond deals, alongside recent analyst rating cuts on Prudential Financial, highlight how the company is simultaneously accessing debt markets while facing fresh external scrutiny of its outlook. With multiple...

If you are wondering whether Toll Brothers is still reasonably priced after its strong run, this article will walk through what the current share price might be implying about value. The stock most recently closed at US$158.65, with a 1% decline over the last 7 days, a 10.9% return over 30 days, a 17.0% return year to date, a 44.6% return over 1 year, and a 175.4% return over 3 years, while the 5 year return is very large. Recent news coverage has focused on Toll Brothers as a key name in US...

Mission Produce (AVO) is back in focus after strong quarterly results highlighted benefits from its vertically integrated model in sourcing and distribution, even as projected revenue declines and low gross margins leave analysts cautious. See our latest analysis for Mission Produce. At a share price of $14.10, Mission Produce has cooled off slightly in the last week, with a 7 day share price return of a 4.73% decline. However, the 90 day share price return of 17.30% and the 1 year total...

VisionWave Holdings (VWAV) has drawn fresh attention after signing a Memorandum of Understanding with partners in Germany and Israel to explore non explosive interceptor drone systems tailored to German Bundeswehr and NATO operational requirements. See our latest analysis for VisionWave Holdings. At a share price of $7.96, VisionWave’s recent MOU, AI radar concept work, governance changes, mining software program, and wider funding activity come against a backdrop of a 30 day share price...

Recent commentary on Hilltop Holdings highlights that over the past five years its net interest income has been flat, earnings per share have fallen about 15% a year, and analysts now expect its efficiency ratio to deteriorate, pointing to mounting profitability pressures. An important implication is that Hilltop may be struggling to adjust its fixed cost base and operations to softer demand, raising questions about how effectively it can respond to industry headwinds. Now we’ll assess how...

Cheniere Energy Partners, L.P. recently reported past fourth-quarter and full-year 2025 results showing higher revenue and net income year over year, while also issuing 2026 distribution guidance of US$3.10–US$3.40 per common unit and maintaining a US$3.10 base distribution. Alongside a very large earnings beat versus analyst expectations, the partnership highlighted its Sabine Pass expansion plans and an S&P rating upgrade to BBB+ with a stable outlook, underscoring its evolving position in...

Intapp (NasdaqGS:INTA) has launched Celeste, a purpose-built agentic AI platform focused on regulated professional services. The company also announced new partnerships with Anthropic to integrate Claude and with Harvey to embed Intapp Walls for ethical compliance in enterprise AI deployments. These moves aim to address compliance-heavy workflows and data governance needs for firms in legal, accounting, and investment banking. For investors watching enterprise software, Intapp sits at the...

Vertex Pharmaceuticals (NasdaqGS:VRTX) has expanded beyond cystic fibrosis with recent approvals for Casgevy, a gene-editing therapy for sickle cell disease and beta-thalassemia. The company also received approval for Journavx, a non-opioid acute pain medication, widening its presence in serious disease areas. These new therapies mark a shift from reliance on a single therapy area to a broader portfolio in gene-editing and pain management. For investors tracking Vertex Pharmaceuticals, the...

Hims & Hers Health (HIMS) is back in the spotlight after its Q4 2025 earnings per share beat, which contrasted with softer Q1 2026 revenue guidance and mounting regulatory and legal pressures. See our latest analysis for Hims & Hers Health. Those mixed earnings and guidance headlines have landed on a stock that was already under pressure, with a 30 day share price return of 47.44% declines and a year to date share price return of 53.31% declines. The 1 year total shareholder return is a...

If you are wondering whether CVS Health is fairly priced or offering value at its recent levels, you are not alone. This article will walk through what the numbers suggest. The stock last closed at US$78.01, with returns of 0.9% over the past 7 days, 8.3% over 30 days, a 2.6% decline year to date, and 25.6% over 1 year. This gives investors a mix of recent momentum and earlier pullbacks to think about. Recent news coverage has focused on CVS Health's position as a large integrated healthcare...

Shopify is rolling out AI driven merchant services that plug directly into its commerce platform, including tools for product discovery, conversational shopping, and operational support. The company has partnered with AI platforms such as OpenAI so shoppers can browse and buy within AI chat experiences while Shopify maintains control of the checkout layer. These moves are designed to enable end to end AI agent powered shopping using Shopify's checkout system, reshaping how merchants and...